Compounds that inhibit MCL-1 protein


Ontology type: sgo:Patent     


Patent Info

DATE

2019-05-28T00:00

AUTHORS

BROWN SEAN P , LI KEXUE , LI YUNXIAO , STEC MARKIAN M

ABSTRACT

Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, or a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer. More... »

Related SciGraph Publications

  • 2008-12-16. Mcl-1 is a potential therapeutic target in multiple types of cancer in CELLULAR AND MOLECULAR LIFE SCIENCES
  • 2008-12. BCL-2 family antagonists for cancer therapy in NATURE REVIEWS DRUG DISCOVERY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0305", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "name": "BROWN SEAN P", 
            "type": "Person"
          }, 
          {
            "name": "LI KEXUE", 
            "type": "Person"
          }, 
          {
            "name": "LI YUNXIAO", 
            "type": "Person"
          }, 
          {
            "name": "STEC MARKIAN M", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00018-008-8637-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023498818", 
              "https://doi.org/10.1007/s00018-008-8637-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd2658", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030857223", 
              "https://doi.org/10.1038/nrd2658"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-05-28T00:00", 
        "description": "

    Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I,

    \n

    \"embedded
    \nor a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.\n

    ", "endDate": "2038-03-28", "id": "sg:patent.US-10300075-B2", "name": "Compounds that inhibit MCL-1 protein", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.417886.4", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-10300075-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-09-02T16:21", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/patent/patent_46.jsonl", "type": "Patent" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-10300075-B2'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-10300075-B2'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-10300075-B2'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-10300075-B2'


     

    This table displays all metadata directly associated to this object as RDF triples.

    46 TRIPLES      15 PREDICATES      18 URIs      9 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:patent.US-10300075-B2 schema:about anzsrc-for:03
    2 anzsrc-for:0305
    3 schema:author Na637d89304464ccb93fe659f0b5beb59
    4 schema:citation sg:pub.10.1007/s00018-008-8637-6
    5 sg:pub.10.1038/nrd2658
    6 schema:datePublished 2019-05-28T00:00
    7 schema:description <p id="p-0001" num="0000">Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I,</p> <p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="45.04mm" wi="69.43mm" file="US10300075-20190528-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif" orientation="portrait" inline="no"/><attachments><attachment idref="CHEM-US-00001" attachment-type="cdx" file="US10300075-20190528-C00001.CDX"/><attachment idref="CHEM-US-00001" attachment-type="mol" file="US10300075-20190528-C00001.MOL"/></attachments></chemistry><br/> or a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer. </p>
    8 schema:endDate 2038-03-28
    9 schema:name Compounds that inhibit MCL-1 protein
    10 schema:recipient grid-institutes:grid.417886.4
    11 schema:sameAs https://app.dimensions.ai/details/patent/US-10300075-B2
    12 schema:sdDatePublished 2022-09-02T16:21
    13 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    14 schema:sdPublisher Nc3228f5475a8419cb4f05acd2944761a
    15 sgo:license sg:explorer/license/
    16 sgo:sdDataset patents
    17 rdf:type sgo:Patent
    18 N000d07aa3f344b91a5c9479628ac8182 schema:name BROWN SEAN P
    19 rdf:type schema:Person
    20 N1032890c120c4bdebc33fd2884a1b7af schema:name LI KEXUE
    21 rdf:type schema:Person
    22 N2f46f0ff21fc480a986d345dd995ad42 schema:name LI YUNXIAO
    23 rdf:type schema:Person
    24 N5da4291fa3994a0dba6111fa46acd983 schema:name STEC MARKIAN M
    25 rdf:type schema:Person
    26 N8c0e9343d26f4152b51825bf10d19ce0 rdf:first N1032890c120c4bdebc33fd2884a1b7af
    27 rdf:rest Ne437e184fd4c4b5984742592c8bb8a8c
    28 Na637d89304464ccb93fe659f0b5beb59 rdf:first N000d07aa3f344b91a5c9479628ac8182
    29 rdf:rest N8c0e9343d26f4152b51825bf10d19ce0
    30 Nacafc2a48ec9446aaf0397fecf5222ec rdf:first N5da4291fa3994a0dba6111fa46acd983
    31 rdf:rest rdf:nil
    32 Nc3228f5475a8419cb4f05acd2944761a schema:name Springer Nature - SN SciGraph project
    33 rdf:type schema:Organization
    34 Ne437e184fd4c4b5984742592c8bb8a8c rdf:first N2f46f0ff21fc480a986d345dd995ad42
    35 rdf:rest Nacafc2a48ec9446aaf0397fecf5222ec
    36 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
    37 rdf:type schema:DefinedTerm
    38 anzsrc-for:0305 schema:inDefinedTermSet anzsrc-for:
    39 rdf:type schema:DefinedTerm
    40 sg:pub.10.1007/s00018-008-8637-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023498818
    41 https://doi.org/10.1007/s00018-008-8637-6
    42 rdf:type schema:CreativeWork
    43 sg:pub.10.1038/nrd2658 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030857223
    44 https://doi.org/10.1038/nrd2658
    45 rdf:type schema:CreativeWork
    46 grid-institutes:grid.417886.4 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...